Ofer Levy

Research activity per year

Fingerprint

Dive into the research topics where Ofer Levy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

213 Article
45 Review article
13 Comment/debate
8 Chapter
More

Discovery of a small molecule TLR3 agonist adjuvant
Lee, B., Dong, D., Nanishi, E., Awad, J. M., Abedi, K. Z., Saito, Y., Borriello, F., Barman, S., Brook, B., Kelly, A., Menon, M., Marques-Mourlet, C., Gupta, M. V., Lister, I., Oh, C., Lyskawa, K., Goetz, M., Walker, K., Cheng, W. K. & Brightman, S. E. & 14 others, Sharma, P., O’Meara, T. R., Chew, K., Vieira, D., Ryff, K., Sweitzer, C., Thomas, S., van Haren, S. D., Pettengill, M., Seo, H. S., Dhe-Paganon, S., Zhang, W., Levy, O. & Dowling, D. J., Dec 2026, In: Nature Communications. 17, 1, 364.
Research output: Contribution to journal › Article › peer-review

Open Access
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
IMPACC Network, Dec 2026, In: Communications Medicine. 6, 1, 1.
Research output: Contribution to journal › Article › peer-review

Open Access
Ontogeny of plasma cytokine and chemokine concentrations across the first four months of human life in a Papua new Guinean cohort
on behalf of EPIC-HIPC consortium, Jan 2026, In: Cytokine. 197, 157076.
Research output: Contribution to journal › Article › peer-review
A multiomics recovery factor predicts long COVID in the IMPACC study
Gabernet, G., Maciuch, J., Gygi, J. P., Moore, J. F., Hoch, A., Syphurs, C., Chu, T., Jayavelu, N. D., Corry, D. B., Kheradmand, F., Baden, L. R., Sekaly, R. P., McComsey, G. A., Haddad, E. K., Cairns, C. B., Rouphael, N., Fernandez-Sesma, A., Simon, V., Metcalf, J. P. & Higuita, N. I. A. & 37 others, Hough, C. L., Messer, W. B., Davis, M. M., Nadeau, K. C., Pulendran, B., Kraft, M., Bime, C., Reed, E. F., Schaenman, J., Erle, D. J., Calfee, C. S., Atkinson, M. A., Brakenridge, S. C., Melamed, E., Shaw, A. C., Hafler, D. A., Augustine, A. D., Becker, P. M., Ozonoff, A., Bosinger, S. E., Eckalbar, W., Maecker, H. T., Kim-Schulze, S., Steen, H., Krammer, F., Westendorf, K., Network, I., Peters, B., Fourati, S., Altman, M. C., Levy, O., Smolen, K. K., Montgomery, R. R., Diray-Arce, J., Kleinstein, S. H., Guan, L. & Ehrlich, L. I. R., 3 Nov 2025, In: Journal of Clinical Investigation. 135, 21, p. 1-17 17 p., e193698.
Research output: Contribution to journal › Article › peer-review

Open Access
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
IMPACC Network, 2025, In: Frontiers in Medicine. 12, 1604388.
Research output: Contribution to journal › Article › peer-review

Open Access

Ofer Levy

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Discovery of a small molecule TLR3 agonist adjuvant

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Ontogeny of plasma cytokine and chemokine concentrations across the first four months of human life in a Papua new Guinean cohort

A multiomics recovery factor predicts long COVID in the IMPACC study

Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study

Ofer Levy

Fingerprint

Collaborations and top research areas from the last five years

Research output

Discovery of a small molecule TLR3 agonist adjuvant

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Ontogeny of plasma cytokine and chemokine concentrations across the first four months of human life in a Papua new Guinean cohort

A multiomics recovery factor predicts long COVID in the IMPACC study

Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study